Search Results
Mar 20, 2026, 09:06 ET MDA SPACE ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION IN INITIAL PUBLIC OFFERING IN THE UNITED STATES
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there.Forward-Looking
More news about: MDA Space
Mar 20, 2026, 08:00 ET Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Mar 20, 2026, 05:26 ET Persistent Appoints Hari S. Abhyankar as Executive Vice President and Global Head of Private Equity and Professional Services
fundamentally different approach, one that integrates strategy with execution and scales results across the portfolio. Persistent's engineering-led DNA and focus on AI-driven transformation position it strongly to address this need. I look forward to working with our clients and partners to accelerate
More news about: Persistent Systems
Mar 20, 2026, 05:18 ET Persistent Appoints Hari S. Abhyankar as Executive Vice President and Global Head of Private Equity and Professional Services
fundamentally different approach, one that integrates strategy with execution and scales results across the portfolio. Persistent's engineering-led DNA and focus on AI-driven transformation position it strongly to address this need. I look forward to working with our clients and partners to accelerate
More news about: Persistent Systems
Mar 20, 2026, 05:15 ET Deepcoin Becomes Official Regional Sponsor of the Argentine Football Association (AFA)
will further extend our global reach and create more opportunities for fans to connect with the glory of our champions."Resonance of Champion DNA: Driven By PassionDeepcoin believes that the pursuit of an ultimate trading experience shares the same core values as peak competitive sports.
More news about: Deepcoin
Mar 19, 2026, 22:36 ET Chiayi International Art Doc Film Festival 2026: A Global Intersection of Land Art and AI Ethics
Child by Swiss director Simon Jaquemet. During the Q&A, Jaquemet shared the film's personal origins—rooted in the tension of waiting for his child's DNA screening. This "existential suspense" led to a broader discussion on AI. While acknowledging its efficiency, Jaquemet urged artists to balance curiosity
More news about: Chiayi International Art Doc Film Festival
Mar 19, 2026, 22:29 ET Basecamp Research lança Trillion Gene Atlas para ampliar terapias desenvolvidas por IA
especificamente para o treinamento em IA. Ao ser pioneira em uma combinação de novas estruturas regulatórias e econômicas e tecnologias de sequenciamento de DNA totalmente fora da rede, a empresa coleta dados genômicos de alta qualidade de ecossistemas fora do alcance dos laboratórios tradicionais.Essas
More news about: Basecamp Research
Mar 19, 2026, 22:04 ET Basecamp Research 推出 Trillion Gene Atlas（萬億基因組圖譜）以規模化人工智能設計療法
NVIDIA Parabricks 的強大功能，顯著加快宏基因組 (metagenomic) 的組裝速度。 此次合作聚焦於先進工程和新演算法方式的開發，以使複雜環境樣本的重建方式更加完善。 得益於此，處理數以萬億計的 DNA 鹼基對 (DNA base pairs) 這項原本需要耗時超過 20 年的浩大工程，預計將可在 2 年內大功告成。合作夥伴預計，通過導入並行數據處理、自動化註解以及大規模模型訓練，這項原本耗時超過 20 年的工作，最終能壓縮至短短 2 年內完成。 這種對測序、組裝、註釋和模型訓練的壓縮，旨在擴大生物基礎模型在治療開發中的性能和範圍。
More news about: Basecamp Research
Mar 19, 2026, 19:58 ET The Choice of the World's Busiest Airports: How AirportLabs is Redefining Operational Simplicity
Built for the Realities of the Airfield: Engineering with DNAThe AirportLabs difference is rooted in an engineering DNA that prioritises resilience over rhetoric. The solutions are cloud-native from the very first line of code, utilising
More news about: AirportLabs Limited
Mar 19, 2026, 13:30 ET T. ROWE PRICE AND OAK HILL ADVISORS LAUNCH MULTI-STRATEGY CREDIT INTERVAL FUND "OFLEX" FOR U.S. WEALTH CLIENTS
volatility, making the Fund an option to complement investors' existing portfolio allocations."Multi‑strategy credit investing has been core to OHA's DNA since inception," said Glenn August, Founder & Chief Executive Officer of OHA. "OFLEX is built to seek to capitalize on our best ideas across the
More news about: T. Rowe Price Group
Mar 19, 2026, 10:01 ET SUPER73® DEBUTS ALL-NEW "A-SERIES" LINEUP OF ELECTRIC BIKES BUILT FOR THE COMMUTER AND DESIGNED TO REDEFINE ELECTRIC MOBILITY
its latest A-Series models. This novel lineup shakes up the brand's traditional platform DNA with the launch of a collection that is for riders looking for both an unrivaled product and a defiant ride. Each bike comes with a complete redesign
More news about: SUPER73
Mar 19, 2026, 10:01 ET Preimplantation Genetic Testing Market to Reach US$ 1,081.9 Million by 2033 Amid Rising IVF Adoption and Technological Innovation - Persistence Market Research
patients. AI-driven image analysis predicts embryo viability with high accuracy, reducing diagnostic errors. Non-invasive PGT methods using cell-free DNA further minimize embryo damage while maintaining precision. Automation and integrated lab platforms streamline workflows, enhancing efficiency and reducing
More news about: Persistence Market Research Pvt. Ltd.
Mar 19, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papilloma virus ("HPV"). The Company's DNA medicines are comprised of two components: (i) DNA plasmids, which are small circular DNA molecules that purportedly work like
More news about: Pomerantz LLP
Mar 19, 2026, 07:30 ET Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
thicker plaques and lesions. This treatment approach avoids the risk of secondary malignancies (including melanoma) inherent with the frequently employed DNA-damaging drugs and other phototherapy that are dependent on ultraviolet exposure. Combined with photoactivation, hypericin has demonstrated significant
More news about: SOLIGENIX, INC.
Mar 19, 2026, 06:00 ET No 'Growth At All Costs': 74% Of Crypto Providers Choose Verification Accuracy Over Speed - New Sumsub Report
maturity means building better systems, not just adding more rules. The platforms that win will be those that embed verification into their product DNA and wrap automation in strong controls, transparency, and accountability," explains Ilya Brovin, Chief Growth Officer at Sumsub. "In
More news about: Sumsub
Mar 18, 2026, 21:44 ET Basecamp Research startet den Trillion Gene Atlas, um KI-entwickelte Therapeutika zu skalieren
für das KI-Training entwickelt wurde. Durch die Kombination neuer regulatorischer und wirtschaftlicher Rahmenwerke mit vollständig netzunabhängigen DNA-Sequenzierungstechnologien erhebt das Unternehmen hochwertige Genomdaten aus Ökosystemen, die außerhalb der Reichweite klassischer Labore liegen.Diese
More news about: Basecamp Research
Mar 18, 2026, 18:13 ET 베이스캠프 리서치, 트릴리언 진 아틀라스 출범으로 AI 설계 치료제 확대 나서
생물다양성 파트너십베이스캠프 리서치는 지난 6년간 31개국을 망라한 과학 협력 네트워크를 구축하며, AI 학습을 위해 특별히 설계된 확장 가능한 진화 유전체 파이프라인을 마련했다. 새로운 규제 및 경제 프레임워크와 완전 오프그리드(off-grid) DNA 시퀀싱 기술의 결합을 선도해 기존 실험실에서는 접근할 수 없던 생태계에서 고품질 유전체 데이터를 수집하고 있다.이 파트너십은 근간은 지식 교류, 현지 역량 강화, 디지털 염기서열 정보와 관련된 신설 규제에 부합하는 공정한 접근 및 이익 공유(Access
More news about: Basecamp Research
Mar 18, 2026, 16:25 ET Baker Hill Establishes Credit Union Advisory Council to Advance Member-Focused Lending Innovation
it's something that has stayed with me throughout my career. It's also reflected in how we approach our work. This isn't a shift for us — it's in our DNA. It represents a significant investment in the future of credit unions, and I'm excited to partner with this group to help shape what comes next."With
More news about: Baker Hill
Mar 18, 2026, 15:43 ET Genome Canada and Ontario Genomics Award Specific Biologics and Western University $1.8 Million Grant to Develop a Machine Learning Platform to Accelerate the Development of the Company's Dualase®-based Therapeutics
programmable repair of small and large DNA sequences, offering broad therapeutic potential. Uniquely, its two-site mechanism precisely targets and collapses toxic DNA repeat expansions with no off-target effects detected. The company's lead preclinical program targets the toxic DNA repeat expansion in C9ORF72 amyotrophic
More news about: Specific Biologics Inc.
Mar 18, 2026, 15:43 ET Genome Canada and Ontario Genomics Award Specific Biologics and Western University $1.8 Million Grant to Develop a Machine Learning Platform to Accelerate the Development of the Company's Dualase®-based Therapeutics
programmable repair of small and large DNA sequences, offering broad therapeutic potential. Uniquely, its two-site mechanism precisely targets and collapses toxic DNA repeat expansions with no off-target effects detected. The company's lead preclinical program targets the toxic DNA repeat expansion in C9ORF72 amyotrophic
More news about: Specific Biologics Inc.
Mar 18, 2026, 13:45 ET MDA Space awarded contract with Canadian Department of National Defence to deliver Ground-Based Optical Capability for Space Surveillance
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Mar 18, 2026, 10:27 ET Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study
antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.
More news about: Kelun-Biotech
Mar 18, 2026, 10:00 ET New England Biolabs® releases EnClose™ Cell-free dbDNA™ Synthesis Kit in collaboration with Touchlight to accelerate DNA and RNA therapeutic development
pioneering enzymatic GMP DNA production to enable the genetic medicine revolution. As pioneers, with an FDA Drug Master File accepted in 2022 followed in 2025 with the world's first cell-free DNA GMP license,Touchlight's enzymatic DNA technology is on the cutting edge of AAV, mRNA, DNA vaccine, and gene
More news about: New England Biolabs, Inc.
Mar 18, 2026, 09:15 ET Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Mar 18, 2026, 09:02 ET GRETSCH UNVEILS THE ELECTROMATIC® PREMIER JET®: THE NEXT EVOLUTION IN BOLD, BOUNDARY-DEFYING SOUND
Premier Jet®, the boldest evolution yet of its celebrated Electromatic and Streamliner™ Jet series. Honoring authentic Gretsch DNA while delivering uncompromising playability and premium appointments, the Electromatic Premier Jet is engineered for the next generation of players who
More news about: Fender Musical Instruments Corporation